Pursuant to regulation 33 of SEBI(LODR), 2015, we are pleased to submit the financial results for the Quarter/ Nine months ended 31st December, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Natraj Proteins Ltd reported its Q3 FY26 and nine-month FY26 standalone unaudited results. Revenue from operations fell to Rs. 2,876.96 lakhs in Q3 FY26 from Rs. 3,340.74 lakhs in Q3 FY25, a decline of about 14%. For the nine months, revenue dropped to Rs. 8,224.87 lakhs from Rs. 9,472.51 lakhs, a similar decline. Despite weaker sales, profitability improved sharply with a Q3 profit of Rs. 289.13 lakhs (vs Rs. 5.31 lakhs a year ago) and a nine-month profit of Rs. 2.67 lakhs versus a loss of Rs. 272.38 lakhs in the prior year period. Total expenses fell meaningfully, expanding operating margins. Q3 EPS rose to Rs. 1.72 from Rs. 0.09. The auditor, Bhutoria Ganesan & Co, issued a clean limited review report with no qualifications.
Topline continued to shrink, which is a concern, but the company swung back to profit on better cost control — a positive turnaround for shareholders. Watch whether revenue stabilises in coming quarters to confirm a sustainable recovery.